It's a shame because it's nice tech and a good idea. But mismanagement and delays have lead this company to ruin. It's going to take another pile of investors and better management to turn this around. Are you going to find enough investment money to give this company a second chance? Doubtful with oil prices so low.
Best in class treatment, and the HepC market isn't going anywhere even though the naysayers say we are late to the party. Nonsense. And Gild has given up on their short term cure because they know they can't compete with JNJ and ACHN there. They're smart enough to not throw good money after bad.
On paper these seem like good logical ideas. However, Wall Street makes its living off of people stopping out of stocks. That is how they drive their Ferraris and live on the beachfront.
Of course, everyone wishes they sold higher. But the bottom line is when you get stopped out of a stock due only to price action, you have played right into their hands. The only defense retail has is time. Since the stock market is simply a tool for computer programs to make money off of the uninitiated, you can't sell just because of poor price action. There has to be a reason. Otherwise you are just another sucker that they have played.
Currently ACHN simply provides no reason to sell the shares on as fundamental basis. They are solid financially, as well as their pipeline. JNJ has removed 95% of the downside risk near term.
The real problem is the upside was greatly reduced, which has lead to many cutting their losses and looking for the next big thing. However it is a mirage, as the entire biotech sector has been absolutely decimated.
The best thing to do is wait it out. The programs will change course in due time. Usually the winter months get "hot", as the broker dealers want to entice the yearly influx of IRA money into their sector. So there will be a lot of window dressing to create excitement.
Understand how wall street works, and you will realize that selling because of price action alone, is exactly what they want you to do and exactly how to go broke. Having stop losses is just dying slower.
89% is really pretty poor. When the better cure comes from JNJ ACHN I guess GILD will have to move on from the space or maybe sell their product at a steep discount.
Unless you are privy to the inner workings of the company, what makes you think you would see it coming? If binary events were easy to predict, or even logical, they wouldn't be binary events.
That's what happens to people who flip for quarters on the short side, sooner or later. See your future, Mac.
First in class treatment, and contrary to what the naysayers have said, HepC market is not going away anytime soon.
Bull, you covered nothing and are underwater. Congrats on selling the bottom. Be sure to tell us all about any cost averaging up you do on your losing position.
Does this stock trade on multiple exchanges? I have seen different floats reported for foreign companies before. There may be a 30:1 ratio for the NASDAQ shares here for example.
Just guessing so don't shoot me. I just started looking at this company.